{
    "Project Title": "Protocol 251PP301",
    "Sponsor": "Biogen MA Inc.",
    "Study Number": "251PP301",
    "Protocol Version and Date": "Version 7",
    "Study Title": "Phase 2b Study of BIIB092 in Participants with Progressive Supranuclear Palsy",
    "Phase": "Phase 2b",
    "Therapeutic Area": "Progressive Supranuclear Palsy",
    "Number of Patients": "Approximately 459 participants",
    "Number of Sites": "Approximately 98 sites planned globally",
    "Indication": "Progressive Supranuclear Palsy",
    "Duration of Treatment": "52 weeks for double-blind treatment, followed by an open-label extension period",
    "Schedule of Assessments": "Table 1, Table 2, Table 3, Table 4",
    "questionnaires": [
        {
            "longName": "Progressive Supranuclear Palsy Rating Scale",
            "shortName": "PSPRS",
            "type": "ClinRO",
            "questionnaireSchedule": "At Weeks 4, 8, 16, 20, and others as specified",
            "questionnaireTiming": [
                "Procedure: Screening Visit",
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: Week48  (\u00b13 days)",
                "Procedure: Week 52  (\u00b13 days)",
                "Procedure: Early  Discontinuation,",
                "Procedure: 12 week intervals after Week 52c  (\u00b17 days)",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 64, 88,  112, 136, 160, 184  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)"
            ]
        },
        {
            "longName": "Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale, Part II",
            "shortName": "MDS-UPDRS Part II",
            "type": "ClinRO",
            "questionnaireSchedule": "As per study schedule at Weeks 4, 8, 16, 20 and others.",
            "questionnaireTiming": [
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: Week 52  (\u00b13 days)",
                "Procedure: Early  Discontinuation,",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)"
            ]
        },
        {
            "longName": "Clinical Global Impression of Severity",
            "shortName": "CGI-S",
            "type": "ClinRO",
            "questionnaireSchedule": "At Week 52",
            "questionnaireTiming": [
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Early Discontinuation"
            ]
        },
        {
            "longName": "Clinical Global Impression of Change",
            "shortName": "CGI-C",
            "type": "ClinRO",
            "questionnaireSchedule": "At Week 52",
            "questionnaireTiming": [
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Early Discontinuation"
            ]
        },
        {
            "longName": "Repeatable Battery for the Assessment of Neuropsychological Disease Severity",
            "shortName": "RBANS",
            "type": "ClinRO",
            "questionnaireSchedule": "At Week 52",
            "questionnaireTiming": [
                "Procedure: Screening Visit",
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: Week 52  (\u00b13 days)",
                "Procedure: Early  Discontinuation,",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)"
            ]
        },
        {
            "longName": "Schwab and England Activities of Daily Living Scale",
            "shortName": "SEADL",
            "type": "ClinRO",
            "questionnaireSchedule": "At Weeks 48 & 52",
            "questionnaireTiming": [
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)",
                "Procedurea: Week 0  (Day 1)",
                "Procedurea: (\u00b13 days)  Weeks  12, 24, 36",
                "Procedurea: Week 48  (\u00b13 days)"
            ]
        },
        {
            "longName": "Phonemic Fluency Test",
            "shortName": "Phonemic Fluency",
            "type": "PRO",
            "questionnaireSchedule": "At Weeks 48 & 52",
            "questionnaireTiming": [
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)",
                "Procedurea: Week 0  (Day 1)",
                "Procedurea: (\u00b13 days)  Weeks  12, 24, 36",
                "Procedurea: Week 48  (\u00b13 days)"
            ]
        },
        {
            "longName": "Letter-Number Sequencing Test",
            "shortName": "LNS",
            "type": "PRO",
            "questionnaireSchedule": "At Weeks 48 & 52",
            "questionnaireTiming": [
                "Procedure: Screening Visit",
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)",
                "Procedurea: Week 0  (Day 1)",
                "Procedurea: (\u00b13 days)  Weeks  12, 24, 36",
                "Procedurea: Week 48  (\u00b13 days)"
            ]
        },
        {
            "longName": "Color Trails Test",
            "shortName": "CTT",
            "type": "PRO",
            "questionnaireSchedule": "At Weeks 48 & 52",
            "questionnaireTiming": [
                "Procedure: Screening Visit",
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: Week48  (\u00b13 days)",
                "Procedure: Week 52  (\u00b13 days)",
                "Procedure: Early  Discontinuation,",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)",
                "Procedurea: Week 0  (Day 1)",
                "Procedurea: (\u00b13 days)  Weeks  12, 24, 36",
                "Procedurea: Week 48  (\u00b13 days)"
            ]
        },
        {
            "longName": "Montreal Cognitive Assessment",
            "shortName": "MoCA",
            "type": "PRO",
            "questionnaireSchedule": "At Weeks 48 & 52",
            "questionnaireTiming": [
                "Procedure: Screening Visit",
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedurea: Week 0  (Day 1)",
                "Procedurea: (\u00b13 days)  Weeks  12, 24, 36",
                "Procedurea: Week 48  (\u00b13 days)"
            ]
        },
        {
            "longName": "Progressive Supranuclear Palsy Quality of Life scale",
            "shortName": "PSP-QoL",
            "type": "PRO",
            "questionnaireSchedule": "At Week 52",
            "questionnaireTiming": [
                "Procedure: Screening Visit",
                "Procedure: Week0  (Day 1)",
                "Procedure: Weeks 12,  24,36  (\u00b13 days)",
                "Procedure: Week48  (\u00b13 days)",
                "Procedure: Week 52  (\u00b13 days)",
                "Procedure: Early  Discontinuation,",
                "Procedure: 12 week intervals after Week 52c  (\u00b17 days)",
                "Procedure: 24 week intervals after Week 52d  (\u00b17 days)",
                "Procedure: Weeks 64, 88,  112, 136, 160, 184  (\u00b17 days)",
                "Procedure: Weeks 76, 100,  124,148,172,196  (\u00b17 days)"
            ]
        }
    ]
}